Niclosamide ethanolamine improves kidney injury in db/db mice
-
Add time:09/25/2019 Source:sciencedirect.com
AimsEarly diabetic kidney disease (DKD) is characterized by renal hypertrophy and albuminuria. The mTOR signal pathway is closely related to DKD. This study was performed to determine the renal protection of niclosamide ethanolamine salt (NEN) which was identified as mTOR inhibitor.
We also recommend Trading Suppliers and Manufacturers of Niclosamide ethanolamine salt (cas 1420-04-8). Pls Click Website Link as below: cas 1420-04-8 suppliers
Prev:Full length articleNiclosamide ethanolamine induces trachea relaxation and inhibits proliferation and migration of trachea smooth muscle cells
Next:Original articleRepositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ResearchFull Report: Basic and Translational—LiverComputational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling09/30/2019
- Design, synthesis and characterization of poly (methacrylic acid-niclosamide) and its effect on arterial function09/29/2019
- ReviewNiclosamide: Beyond an antihelminthic drug09/28/2019
- Dissipation, residues and risk assessment of metaldehyde and niclosamide ethanolamine in pakchoi after field application10/01/2019
- Niclosamide ethanolamine inhibits artery constriction09/27/2019
- Original articleRepositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity09/26/2019
- Full length articleNiclosamide ethanolamine induces trachea relaxation and inhibits proliferation and migration of trachea smooth muscle cells09/24/2019
-
Health and Chemical more >


